Cambridge Bioscience, through our collaboration with Chantest, offers customers throughout Europe the most comprehensive range of ion channel screening services available today. Chantest have repeatedly been recognised as the World’s leading ion channel service provider in surveys of industry experts.

At the core of our ion channel screening service capabilities is the largest commercial collection of validated stable cell lines expressing ion channel targets. With over 90 ion channel targets available today, Chantest are able to undertake the most complete studies to determine efficacy and selectivity for new ion channel drugs.

This massive cell line library is further supported by Chantest’s commitment to offer services across the widest range of screening platforms, from manual patch clamp up to the most recent innovations in automated electrophysiology, allowing you to select the right balance of speed, throughput and data quality to suit your needs.

To learn more about our ion channel screening services, please contact us by email.

Products

Note: product availability depends on country. Product detail pages show availability of each product.